Induction of drug metabolism: a comparative, pharmacokinetic in vivo study of the effect of carbamazepine and oxcarbazepine on CYP3A4

Trial Profile

Induction of drug metabolism: a comparative, pharmacokinetic in vivo study of the effect of carbamazepine and oxcarbazepine on CYP3A4

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2015

At a glance

  • Drugs Oxcarbazepine (Primary) ; Carbamazepine
  • Indications Epilepsy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 21 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 13 Jan 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top